The total return over the past 12 months is -92.28% vs. +16.94% for the S&P 500. So far it's up -72.38% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (92.28%) | (38.75%) | (66.75%) | (64.11%) | N/A | N/A |
| Total Return CAGR | (92.28%) | (38.75%) | (66.75%) | (64.11%) | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Tempest Therapeutics, Inc. (TPST)
| Year | Start price | End price | TPST Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $2.87 | $0.79 | (72.38%) | +14.51% | (86.89%) |
| 2025 | $10.85 | $2.87 | (73.55%) | +17.72% | (91.27%) |
| 2024 | $57.20 | $10.85 | (81.03%) | +24.89% | (105.92%) |
| 2023 | $14.95 | $57.20 | +282.61% | +26.19% | +256.42% |
| 2022 | $68.64 | $14.95 | (78.22%) | (18.17%) | (60.05%) |
| 2021 | $417.30 | $68.64 | (83.55%) | +28.74% | (112.29%) |
| 2020 | $1,314.30 | $417.30 | (68.25%) | +18.37% | (86.62%) |
| 2019 | $1,550.25 | $1,314.30 | (15.22%) | +31.22% | (46.44%) |
| 2018 | $4,092.95 | $1,550.25 | (62.12%) | (4.56%) | (57.56%) |
| 2017 | $4,473.01 | $4,092.95 | (8.50%) | +21.70% | (30.20%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
